Larvol Delta - CERo-also-plans-a-Phase-1-study-in-NSCLC-and-ovarian-cancer-leveraging-the-same-CER1236-mechanism-against-solid-tumors-with-initiation-anticipated-in-2026

CER-1236 - CERo Therap

https://www.stocktitan.net/sec-filings/CERO/10-k-cero-therapeutics-holdings-inc-files-annual-report-46d7f37dffca.html

Apr 15, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next